Press release
FIECON Unleashes Unprecedented Access to Payer and Commercialisation Titans
FIECON Strategic Council - Susan Suponcic, Dawn Lee and Eric Low commercial, payer, and patient advocacy experts.
The FIECON Strategic Council is a powerhouse team of executive leaders, poised to provide clients with unparalleled access to high-calibre expertise across commercial, payer, and patient advocacy. The Strategic Council comprises three eminent experts - Dawn Lee, Eric Low, and Susan Suponcic.
Dawn Lee is a distinguished Associate Professor of Health Economics and Health Policy at the Peninsula Technology Assessment Group (PenTAG). Dawn is a current payer, leading an Evidence Review Group and serving as a NICE committee member. She is an exceptional health economist with a track record of over 50 UK Health Technology Assessment submissions and global expertise spanning more than 30 countries.
Eric Low, OBE is a visionary key opinion leader with an unwavering commitment to patient outcomes and rare diseases' prevention and curability. He is a leading authority in orphan drugs and melanoma medical research, local market access and patient organisations in the UK. Notably, he founded Myeloma UK and currently runs a consultancy specialising in strategic market access, healthcare policy, and patient engagement.
Dr Susan Suponcic brings a wealth of US and Global pricing and market access commercialisation expertise. Her vast experience across US pharmaceutical companies and global consultancies will be leveraged to provide FIECON clients' access to specific US launch and commercialisation expertise.
The formation of the council underscores FIECON's continued commitment to delivering industry-best results, experiences, and partnerships to clients in the pharmaceutical and Medtech industry.
Mark Fisher, CEO of FIECON, explained the vision for the council, "FIECON has redefined the standard of excellence for strategic advice and support for the life sciences industry. Clients can look forward to unprecedented access to these commercialisation titans and an accelerated path to resolving their commercialisation challenges in Global markets, in particular, the dynamic UK and US markets.
The Strategic Council members: Dawn, Eric and Susan will be live at ISPOR Europe in Copenhagen 13th -15th November. For more information about FIECON and its Strategic Council, please karl.freemyer@fiecon.com to start a commercialisation conversation.
Hodgkin Huxley House, 30 Farringdon Lane
EC1R 2AW
Kate Monk kate.benson@fiecon.com
FIECON is a leading life sciences consultancy committed to transforming the landscape of Health Economics and Outcomes Research (HEOR) and Market Access. With a world-class team of experts, FIECON supplies invaluable support to clients in the pharmaceutical and MedTech industry, shaping the future of healthcare access and outcomes.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release FIECON Unleashes Unprecedented Access to Payer and Commercialisation Titans here
News-ID: 3284257 • Views: …
More Releases for Strategic
Meditation Market 2024 Strategic Assessment
In recent years, the global Meditation Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Meditation Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including Porters Five Forces Analysis,…
A' Strategic Design Award Calls for Entries: Recognizing Strategic Design Excell …
The highly acclaimed A' Strategic Design Award, as part of the esteemed A' Design Award & Competition, is now accepting entries for its latest edition. This prestigious accolade aims to celebrate and honor the most outstanding achievements in strategic design, recognizing the visionary designers, innovative agencies, and forward-thinking brands that are shaping the future of the industry. The A' Strategic Design Award serves as a platform for these exceptional talents…
Strategic Planning Software Strategic Assessment and Forecast Till 2025: Planvie …
Latest Research Study on Global Strategic Planning Software Market published by AMA, offers a detailed overview of the factors influencing the global business scope. Global Strategic Planning Software Market research report shows the latest market insights with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors, Challenges and Current Scenario Analysis of the Global Strategic Planning Software.…
Digital Signage Market Report 2023: Key Companies LG Electronics, Microsoft, NEC …
U.S. digital signage market was $4.4 billion for 2015. Rising demand across various application areas is predicted to positively affect the industry growth of the region.
Favourable application overview along with improved user experience is a key factor driving the industry growth in Asia Pacific. Regional demand for the digital signage across transportation segment is predicted to register a CAGR of about 7% during the forecast period.
Digital Signage market share is…
Ethiopia’s strategic cooperation with China
Over the past decade, Ethiopia has experienced an average economic growth rate of about 10%. Ethiopia is expected to grow by 8.5% in 2018, topping China’s projected growth of 6.5%.
In recent times, the Ethiopian government has abandoned its 1970’s Communist ideology and put in place some basic reforms. They went on to build sturdy infrastructure and launch a successful industrial policy, calling to mind China’s own development pathway.
The Chinese have…
Strategic Analysis Of Diethylenetriamine Market
Diethylenetriamine, also abbreviated as DETA serves as an organic compound. It is a colorless hygroscopic liquid which is soluble in polar organic solvents and water, but not simple hydrocarbons. DETA is the structural analogue of diethylene glycol, with chemical properties resembling to those of ethylene diamine with similar uses. Diethylenetriamine is a byproduct which is formed from manufacturing ethylene diamine from ethylene dichloride. DETA is used in a wide range…
